Researchers have successfully developed small placenta or placenta organs in laboratories that can change pregnancy, concept, dead fetus, pregnancy and pregnancy, and disease research.
The results of these organoids have been published in the final issue of the journal Nature.
These organoids compare the placenta with a successful expression at the first stage, explaining the researchers. During this phase, drugs or diseases that affect the placenta may be investigated. In fact, this small placenta feels like placenta, which explains that the team can have a positive effect on pregnancy testing. Professor Ashley Moffett, Professor and Professor of Reproductive Immunology at Cambridge University, said: "If we put the pregnancy out of the body, it's pregnant."
The team explains that there is a problem in the team before the placenta is examined. Healthy placenta develops and affects the uterine walls and adds blood to nutrients and oxygen to growing embryos and fetuses. It not only releases hormones and chemicals that allow the growth of the fetus, but also produces residues of the growing fetus. The placenta also sends hormones to the mother's blood stream that helps to achieve pregnancy. This phenomenon has not yet been studied in humans. With the development of organisms, researchers will be able to understand the functions and function of the placenta. Moffett: "Now we can experiment with the experience of placental development in the uterine environment."
The group used cells from the placental tissue cavity. These villas are like normal placenta structure. These placental cells grown in the laboratory can be transformed into many cell groups or structures acting as a specific placenta by secretion of proteins and hormones. These measurements range from tenth to millimeters to half millimeters and can be stored in frozen form for defrosting only before use.
Experts agree that this study provides invaluable insight into common disorders of pregnancy, including congenital anesthesia (IUGR) and preeclampsia. It can also be investigated how the fetal infection, such as Zica, affects their growth and growth.
Margertita Turco, a leading author of the study, wrote: "Placenta is very important when the baby is growing inside his mother. If it does not work properly, it can lead to immediate and prolonged consequences for the mother and the child, from pre-eclampsia to pregnancy. " The team does not detract from these teratogenic drugs or baby infected with their mother. Placental organoids can also be a source of cellular therapy during pregnancy or threatening in the comments of the team. In short, this can be repeatedly used in pregnancy-related studies of organelles.
According to Moffett, "In 30 years, we have a small placenta that grows in the laboratory for at least one year to reach this point."
Posted in: Medical research news Women's health news